Annexin Pharmaceuticals

Annexin Pharmaceuticals AB is a leading biotechnology company in the field of Annexin A5 for the treatment of various diseases. The company's biological candidate drug, ANXV, is a human recombinant protein, Annexin A5, mainly used for treating patients with vascular injury and inflammation, but also for cancer. The company has an extensive patent portfolio in the treatment of diseases with Annexin A5 and the production of Annexin A5.